High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan-Baluchistan Province, Iran [2]

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1828-1829

  Zakeri, Sedigheh ^a   Gil, J Pedro ^b,c   Bereckzy, Sandor ^b   Djadid, Navid D ^a   Bjorkman, Anders ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

CODON; DRUG EFFICACY; ENDEMIC DISEASE; GENE MUTATION; GENOTYPE; HUMAN; IRAN; LETTER; MALARIA; MIGRATION; PAKISTAN; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REFUGEE; TREATMENT INDICATION;

ANIMALS; ANTIMALARIALS; CODON; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; IRAN; MALARIA, FALCIPARUM; MALE; MUTATION; PLASMODIUM FALCIPARUM; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0038201915     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375250     Document Type: Letter

References (8)

1. Zakeri S, Najafabadi S, Zare A, Djadid N. Detection of malaria parasites by nested PCR in south-eastern, Iran: evidence of highly mixed infections in Chahbahar district. Malar J 2002; 1:2.
2. Edrissian GH, Afshar A, Sayedzadeh A, Mohsseni G, Satvat MT. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulfadoxine-pyrimethamine in the malarious areas of Iran. J Trop Med Hyg 1993; 96:237-40.
3. Rowland M, Durrani N, Hewitt S, Sondorp E. Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test. Trop Med Int Health 1997; 2:1049-56.
4. Kublin JG, Dzinjalamala FK, Kamwendo DD, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002; 185:380-8.
5. Eskandarian AA, Keshavarz H, Basco LK, Mahboudi F. Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran? Trans R Soc Trop Med Hyg 2002; 96:96-8.
6. Duraisingh MT, Curtis J, Warhurst DC. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 1998; 89:1-8.
7. Masimirembwa CM, Phuong-dung N, Phuc BQ, et al. Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase. Int J Antimicrob Agents 1999; 12:203-11.
8. Wang P, Lee CS, Bayoumi R, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 1997; 89:161-77.